Lotus Pharm vs TaiMed Biologics: monthly revenue

Monthly revenue and year-on-year change for Lotus Pharm (1795) and TaiMed Biologics (4147) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ Lotus Pharm ━ TaiMed Biologics

0%+226%-34%25/1026/0126/0426/0726/10

Monthly revenue history

MonthLotus PharmYoYTaiMed BiologicsYoY
Oct 2026NT$2.13 billion-22.5%NT$52.4 million+35.7%
Sep 2026NT$2.77 billion+128.0%NT$53.9 million-9.1%
Aug 2026NT$2.11 billion+81.7%NT$60.5 million+19.5%
Jul 2026NT$2.49 billion+3.9%NT$63.7 million+68.4%
Jun 2026NT$3.4 billion+225.5%NT$45.3 million-16.9%
May 2026NT$2.32 billion+105.8%NT$63.3 million+42.9%
Apr 2026NT$3.09 billion+19.9%NT$47.2 million+21.8%
Mar 2026NT$4.35 billion+173.6%NT$78.4 million+0.5%
Feb 2026NT$2.24 billion+131.5%NT$49.8 million+2.9%
Jan 2026NT$2.05 billion-5.5%NT$37.9 million-24.0%
Dec 2025NT$2.44 billion+66.9%NT$73.3 million+56.9%
Nov 2025NT$1.06 billion-0.2%NT$37.9 million-33.7%
Oct 2025NT$2.75 billion+46.0%NT$38.6 million-7.5%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16